Aspen China






The Aspen Group’s Asia-Pacific presence was extended to include China, where Aspen China was incorporated as a wholly foreign owned enterprise in 2015.

Aspen China’s product range currently comprises the immuno-suppression, hormonal and oncolytic therapeutic categories. The business is seeking appropriate opportunities to meet the Group’s strategic expansion intent in the Chinese market.

For further assistance, please send an email to us here.